Article
Assessment of commercially available computerized neurocognitive testing in the adolescent concussed athlete: A retrospective analysis
Marshall Journal of Medicine
(2020)
Abstract
Background
Clinicians frequently use computer-based neurocognitive assessments to aid in the diagnosis and management
of Sport-Related Concussion (SRC). With practitioners using varied Neuro-Cognitive Assessment
Tools (NCAT), questions arise concerning differences among NCAT and how these differences
may affect patient care. The purpose of the current study is to offer a comparative analysis of two
widely accepted, commercially available computer-based neurocognitive testing modalities in the adolescent
concussed athlete.
Hypothesis
There will be a difference between the C3 Logix® vs ImPACT® scoring in the IRPT and RTP.
Study Design
Retrospective chart review.
Methods
In order to identify patients that were diagnosed with SRC, the records of patients reporting to a sports
medicine practice were reviewed for a period of eighteen months. All patients were assessed with either
the ImPACT® or C3 Logix NCAT®. The date of the injury (DOI), as well as the patient’s symptom
level (IVAL), time to initiation of the return to play protocol (IRTP), and time to the return to play
(RTP), were recorded.
Results
Two hundred and twenty-two records (222) were identified. There was no difference in the symptom
score (P = 0.22) at the IEVAL between C3 Logix® (31.5±27.0) and ImPACT® (23.2±21.9), in the
IRTP (P = 0.22) between the C3 Logix® (6.2±4.3 days) and ImPACT® (5.1±4.3 days) or RTP (P =
0.46) between C3 Logix (12.1±4.9 days) and ImPACT (15.6±19.8 days). Weak to moderate correlations
were found between symptom scores, IRTP, and RTP.
Conclusions
Clinicians made similar recommendations, independent of the NCAT used, as when to initiate the return
to play protocol and when the patient could ultimately return to play.
Clinical Relevance
The particular NCAT utilized by the clinician was not a primary factor in the clinical judgment towards
the management of the patient with SRC.
Keywords
- C3 Logix,
- ImPACT,
- Neurocognitive assessment testing,
- sports-related concussion,
- return to play
Disciplines
Publication Date
2020
DOI
10.33470/2379-9536.1257
Citation Information
Brock Hardin, Andrew C. Gilliland, Thomas Belmaggio, Charles E. Giangarra, et al.. "Assessment of commercially available computerized neurocognitive testing in the adolescent concussed athlete: A retrospective analysis" Marshall Journal of Medicine (2020) Available at: http://works.bepress.com/mark-timmons/4/